Medicines pricing

All Items

• Health Technology Assessment in Portugal: health policies, methodologies and emerging challenges

  Sónia CALDEIRA, Daniella PINGRET-KIPMAN, Fernanda FERRADOR, Sara A. COUTO, Juliana A. ORTIZ, Claudia FURTADO

  861

• Improving medicines access in Brazil through collaboration in the PPRI network

  Sabine VOGLER, Nina ZIMMERMANN

  677

• Italy – a study case of medicines pricing and reimbursement

  Valdete A. MELO, Bruna O. ASCEF, Fabrizio GIANFRATE

  814

• Medicines pricing and reimbursement in Canada

  Chris BONNETT, Tania STAFINSKI, Evelinda TRINDADE

  811

• Medicines regulation, pricing and reimbursement in Brazil

  Adriana M. IVAMA-BRUMMELL, Daniella PINGRET-KIPMAN, Priscila G. LOULY, Rosiene R. ANDRADE

  769

• Pharmaceutical Pricing and Reimbursement Policies: lessons learnt and perspectives for Brazil

  Adriana M. IVAMA-BRUMMELL, Claudia S. OSORIO-DE-CASTRO

  897

• Pharmaceutical regulation and policies in Austria

  Sabine VOGLER

  639

• Pharmaceutical regulation, pricing, coverage and policy reform in the United States of America

  Mariana P. SOCAL, Juliana A. ORTIZ, Fabricio GARCIA, Daniella PINGRET-KIPMAN

  847

• Regulatory intelligence of health technologies in Greece

  Mariana M. BARBOSA, Carolina D. ZAMPIROLLI, Isabella F. ZUPPO, Renata M. NASCIMENTO, Persefoni KRITIKOU, Francisco A. ACURCIO, Juliana ÁLVARES-TEODORO

  789

• The regulatory, evaluation, pricing and reimbursement pathway for medicines in the UK: combining innovation and access

  Adriana M. IVAMA-BRUMMELL, Pilar PINILLA-DOMINGUEZ, Aline N. BIZ

  804